Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 10462544)

Published in Mol Pharmacol on September 01, 1999

Authors

A R Van Rompay1, M Johansson, A Karlsson

Author Affiliations

1: Division of Clinical Virology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

Articles citing this

Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases. Proc Natl Acad Sci U S A (2007) 1.63

Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br J Cancer (2007) 1.61

Structure of the nucleotide radical formed during reaction of CDP/TTP with the E441Q-alpha2beta2 of E. coli ribonucleotide reductase. J Am Chem Soc (2009) 1.32

Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov (2013) 1.27

Insight into the mechanism of inactivation of ribonucleotide reductase by gemcitabine 5'-diphosphate in the presence or absence of reductant. Biochemistry (2009) 1.04

CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer. Nature (2015) 0.99

Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement (2007) 0.93

The contribution of CMP kinase to the efficiency of DNA repair. Cell Cycle (2015) 0.89

Inactivation of Lactobacillus leichmannii ribonucleotide reductase by 2',2'-difluoro-2'-deoxycytidine 5'-triphosphate: covalent modification. Biochemistry (2010) 0.89

Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication. PLoS Comput Biol (2011) 0.84

Gemcitabine pharmacogenomics: deoxycytidine kinase and cytidylate kinase gene resequencing and functional genomics. Drug Metab Dispos (2008) 0.84

Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1. Oncotarget (2016) 0.79

Introduction of a fluorine atom at C3 of 3-deazauridine shifts its antimetabolic activity from inhibition of CTP synthetase to inhibition of orotidylate decarboxylase, an early event in the de novo pyrimidine nucleotide biosynthesis pathway. J Biol Chem (2012) 0.78

The Rv1712 Locus from Mycobacterium tuberculosis H37Rv codes for a functional CMP kinase that preferentially phosphorylates dCMP. J Bacteriol (2009) 0.78

UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulation. Biochem J (2004) 0.78

UMP/CMPK is not the critical enzyme in the metabolism of pyrimidine ribonucleotide and activation of deoxycytidine analogs in human RKO cells. PLoS One (2011) 0.77

Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity. Biochem Biophys Res Commun (2011) 0.75

Comparative Transcriptomic Analysis Reveals Novel Insights into the Adaptive Response of Skeletonema costatum to Changing Ambient Phosphorus. Front Microbiol (2016) 0.75

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients. Sci Rep (2016) 0.75

ADME studies of [5-(3)H]-2'-O-methyluridine nucleoside in mice: a building block in siRNA therapeutics. Pharmacol Res Perspect (2016) 0.75

Acid-base and metal ion binding properties of 2-thiocytidine in aqueous solution. J Biol Inorg Chem (2008) 0.75

A novel viral thymidylate kinase with dual kinase activity. J Bioenerg Biomembr (2015) 0.75

Articles by these authors

Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09

Genetic mapping of quantitative trait loci for growth and fatness in pigs. Science (1994) 5.37

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol (1997) 5.18

Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc (2005) 4.12

Stressful life events and Graves' disease. Lancet (1991) 3.63

Respiratory burst in human neutrophils. J Immunol Methods (1999) 3.16

'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport (1996) 2.60

Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol (1991) 2.59

Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol Microbiol (2000) 2.57

The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group. N Engl J Med (1990) 2.46

Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res (1999) 2.25

Gestational age and growth rate of fetal mass are inversely associated with systolic blood pressure in young adults: an epidemiologic study of 165,136 Swedish men aged 18 years. Am J Epidemiol (2000) 2.18

Herpes simplex virus infection of the human sensory neuron. An electron microscopy study. Arch Virol (1988) 2.08

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease. Aliment Pharmacol Ther (2008) 2.06

Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J Clin Microbiol (1998) 1.99

Chemical transformations in individual ultrasmall biomimetic containers. Science (1999) 1.93

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology (1993) 1.92

Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet (1999) 1.79

Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy. J Virol (1993) 1.75

Trends in overweight and obesity among 18-year-old males in Sweden between 1971 and 1995. Acta Paediatr (1999) 1.71

Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J Clin Oncol (2000) 1.68

Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem (2001) 1.63

Two new serotypes of enteric adenovirus causing infantile diarrhoea. Dev Biol Stand (1983) 1.63

Substrate binding site of naphthalene 1,2-dioxygenase: functional implications of indole binding. J Mol Biol (2000) 1.62

Comparison between permeability coefficients in rat and human jejunum. Pharm Res (1996) 1.59

The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial. BJOG (2014) 1.54

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci U S A (1996) 1.54

Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol (1984) 1.50

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity. J Med Chem (1994) 1.50

Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J Gen Virol (1991) 1.49

Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol (1988) 1.46

The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem (2000) 1.44

T-matrix computations of light scattering by red blood cells. Appl Opt (1998) 1.43

Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab (1984) 1.41

The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood (2000) 1.41

The OSBP-related protein family in humans. J Lipid Res (2001) 1.40

Magic Lite Chlamydia immunoassay in urogenital samples and urine versus chlamydial culture. Int J STD AIDS (1994) 1.39

[Smoking and goiter. Sex, heredity and stress are stronger risk factors]. Lakartidningen (1993) 1.39

[Healthy children]. Ugeskr Laeger (1993) 1.37

Early electrocardiographic changes in acute myocardial infarction treated by streptokinase or alteplase: a randomized study with dynamic, multi-lead, electrocardiographic monitoring. Cardiology (1993) 1.37

Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry (2000) 1.36

Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment. Indoor Air (2005) 1.34

The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem (2001) 1.34

Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol (2006) 1.33

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther (2000) 1.32

Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond) (2007) 1.32

Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc Natl Acad Sci U S A (1998) 1.32

Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31

Is VP22 nuclear homing an artifact? Nat Biotechnol (2001) 1.30

Identification of galactose-α-1,3-galactose in the gastrointestinal tract of the tick Ixodes ricinus; possible relationship with red meat allergy. Allergy (2013) 1.29

Wild birds as a possible natural reservoir of Borna disease virus. Epidemiol Infect (2001) 1.27

Evidence for integrated EBV genomes in Raji cellular DNA. Nucleic Acids Res (1984) 1.27

Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Virology (1993) 1.27

Pharmacokinetics and absorption of foscarnet after intravenous and oral administration to patients with human immunodeficiency virus. Clin Pharmacol Ther (1988) 1.27

Positively and negatively charged residues have different effects on the position in the membrane of a model transmembrane helix. J Mol Biol (1998) 1.27

Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci U S A (1995) 1.26

The relation of weight, length and ponderal index at birth to body mass index and overweight among 18-year-old males in Sweden. Eur J Epidemiol (1998) 1.25

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proc Natl Acad Sci U S A (1993) 1.24

Pharmacokinetics of oral noscapine. Eur J Clin Pharmacol (1990) 1.23

Influenza A in immunocompromised patients. Clin Infect Dis (1993) 1.22

Divergent evolution of membrane protein topology: the Escherichia coli RnfA and RnfE homologues. Proc Natl Acad Sci U S A (1999) 1.22

A primary linkage map of the porcine genome reveals a low rate of genetic recombination. Genetics (1994) 1.20

Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol (1993) 1.19

Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol (2001) 1.19

Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol (1985) (1992) 1.18

Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev (2002) 1.18

Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils. J Immunol (1999) 1.18

99mTechnetium dimercaptosuccinic acid scintigraphy in the diagnosis of acute pyelonephritis in rats. Pediatr Nephrol (1990) 1.17

Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS? BMJ (1994) 1.16

Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochem Pharmacol (1974) 1.15

Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses. Biopharm Drug Dispos (1998) 1.13

Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem (1999) 1.13

Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. J Biol Chem (1993) 1.12

Cloning of the cDNA and chromosome localization of the gene for human thymidine kinase 2. J Biol Chem (1997) 1.11

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. Br J Cancer (2009) 1.11

SMAD genes in juvenile polyposis. Genes Chromosomes Cancer (1999) 1.10

Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev (1997) 1.10

Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site. J Virol (1990) 1.10

Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants. Proc Natl Acad Sci U S A (1994) 1.10

Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med (2003) 1.09

Pharmacokinetic properties of noscapine. Eur J Clin Pharmacol (1982) 1.09

Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. Mol Pharmacol (1996) 1.08

HIV transmission by blood transfusions in Stockholm 1979-1985: nearly uniform transmission from infected donors. AIDS (1988) 1.07

Enteric adenoviruses. Ciba Found Symp (1987) 1.06

Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection. J Chromatogr B Biomed Sci Appl (1998) 1.06

A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients. Br J Clin Pharmacol (1999) 1.05

Effects of acupuncture, cervical manipulation and NSAID therapy on dizziness and impaired head repositioning of suspected cervical origin: a pilot study. Man Ther (2000) 1.04

Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis. J Biol Chem (1993) 1.04

The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem Soc Trans (2006) 1.04

In vivo cell recruitment, cytokine release and chemiluminescence response at gold, and thiol functionalized surfaces. Biomaterials (1999) 1.03

Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe. Infect Immun (2001) 1.03

Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proc Natl Acad Sci U S A (1996) 1.03

A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Eur J Clin Pharmacol (1997) 1.03

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1. J Virol (1997) 1.02

Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues. Mol Pharmacol (1993) 1.02